Best selling Cancer Drugs

      No Comments on Best selling Cancer Drugs

The pharmaceutical industry’s 20 top-selling cancer drugs generate annual sales of over $50 billion worldwide. Celgene’s Revlimid and Roche’s Rituxan, Avastin, and Herceptin lead the pack, with $26 billion in sales for these four drugs alone.

Source

  1. Manufacturer: Celgene. Global sales: $4.2 billion
  2. Manufacturer: Roche. Global sales: $6.7 billion
  3. Manufacturer: Roche. Global sales: $6.5 billion
  4. Manufacturer: Roche. Global sales: $7.5 billion
  5. Manufacturer: Bristol-Myers Squibb; Ono Pharmaceutical. Global sales: $4.7 billion
  6. Manufacturer: Novartis. Global sales: $4.7 billion
  7. Manufacturer: Johnson & Johnson/Pharmacyclics. Global Sales: $5.3 billion
  8. Manufacturer: Johnson & Johnson/Takeda. Global sales: $2.6 billion
  9. Manufacturer: Johnson & Johnson. Global sales: $1.7 billion
  10. Manufacturer: Astellas Pharma/Pfizer. Global sales: $2.371 billion